New developments in vaccines against respiratory viruses.
Respiratory viruses are important human pathogens, affecting both healthy individuals and immunocompromised patients. In the past decade several new human respiratory viruses have been described, some of which have the potential to start an epidemic. At the same time, influenza A viruses continue to constitute a challenge to mankind as they undergo genetic modification. In this review new developments in the field of vaccines against respiratory viruses are presented, in view of the problems encountered during the development of such vaccines in the past, as well as the availability of modern technologies, which make it possible to create novel vaccines.
Wroblewska
Marta
M
Medical University of Warsaw, Department of Medical Microbiology, 5 Chalubinskiego St, 02-004 Warsaw, Poland. wroblewska@ib.amwaw.edu.pl
D000818:Animals; D004266:DNA Virus Infections / Q000276:immunology / Q000517:prevention & control; D004196:Disease Outbreaks / Q000517:prevention & control; D006801:Humans; D012327:RNA Virus Infections / Q000276:immunology / Q000517:prevention & control; D012141:Respiratory Tract Infections / Q000276:immunology / Q000517:prevention & control*; D014765:Viral Vaccines / Q000276:immunology / Q000627:therapeutic use*
D014765:Viral Vaccines